Regulation · Australia

Is GHK-Cu legal
in Australia?

In Australia the same copper peptide can fall under two rulebooks: therapeutic goods, which the TGA regulates, or cosmetics, whose ingredients are regulated as industrial chemicals. Here is where the line runs, and what the TGA has said about GHK-Cu.

Short answerRegulation · 7 min read · Updated 18 Nov 2026

GHK-Cu’s status in Australia depends on the product. The TGA lists GHK-Cu among unapproved peptide products, often supplied in injectable form, and says importing, advertising, manufacturing and supplying unapproved peptide products is unlawful. The Poisons Standard does not name GHK-Cu. The TGA says a peptide product may be regulated as a cosmetic if its ingredients, claims, presentation and intended use are limited to cosmetic purposes.

Key takeaways

  • GHK-Cu is one of five compounds the TGA gave in April 2026 to illustrate unapproved peptide products, a group it says is “often supplied in injectable form”.
  • Under the Therapeutic Goods Act 1989, a product presented for a therapeutic use is a therapeutic good, and one not included in the ARTG is unapproved.
  • The TGA says it does not assess cosmetics unless they make therapeutic claims; cosmetic ingredients are regulated as industrial chemicals under the Industrial Chemicals Act 2019.
  • The October 2026 Poisons Standard does not name GHK-Cu, though it has group entries for copper compounds; separately, the TGA says supplying unapproved peptide products is unlawful.
  • Neither the 2026 nor the 2027 WADA List names GHK-Cu, and Sport Integrity Australia, which counts it among unapproved peptide products, says many of those are prohibited in sport.

01Is GHK-Cu a therapeutic good or a cosmetic in Australia?

It depends on the product, not the molecule. Australian law sorts products by how they are presented and what they are for.

Therapeutic goods. The Therapeutic Goods Act 1989 covers goods represented as being for “therapeutic use”, which includes “influencing, inhibiting or modifying a physiological process in persons”. The TGA’s peptide products page, last updated on 23 September 2026, says a peptide product is regulated as a therapeutic good if, for example, it is “promoted, supplied or generally used for a therapeutic purpose”. Section 19B of the Act makes it an offence to import or supply therapeutic goods for use in humans that are not registered, listed, exempt or approved.

Cosmetics. The same TGA page says: “Some peptide products may be regulated as cosmetics rather than a therapeutic good if their ingredients, claims, presentation and intended use are limited to cosmetic purposes.” The TGA’s cosmetics page adds: “We do not assess cosmetics unless they make therapeutic claims. The ingredients in cosmetics are regulated as industrial chemicals.” That scheme sits under the Industrial Chemicals Act 2019 and is run by the Australian Industrial Chemicals Introduction Scheme (AICIS).

What counts as a cosmetic. Section 9 of that Act defines a cosmetic as a substance or preparation placed in contact with an external part of the body to clean it, perfume it, change its appearance, keep it in good condition, protect it or alter its odours. The definition excludes “a therapeutic good within the meaning of the Therapeutic Goods Act 1989”. An injectable product falls outside it, since the definition covers external parts of the body.

Labels do not decide it. The TGA says “research use only” disclaimers alone do not “change a product’s regulatory status”. More: what “research use only” means.

How the product is presented and usedRegimeWho regulates
An injectable vial, or any product presented for a therapeutic use.Therapeutic good; unapproved unless included in the ARTG.TGA (Therapeutic Goods Act 1989, ss 3 and 19B).
A skin product whose ingredients, claims, presentation and intended use are limited to cosmetic purposes.May be regulated as a cosmetic, the TGA says; cosmetic ingredients are regulated as industrial chemicals.AICIS for ingredients; the ACCC for labelling and product safety, the TGA says.
Any product labelled “research use only”.The label alone does not change the status.TGA.
Any product containing a copper compound.Poisons Standard group entries for copper compounds may apply.States and territories, which give the Standard effect.
Use by athletes in sports under the Code.WADA Prohibited List.Sport Integrity Australia.

02What has the TGA said about GHK-Cu?

TGA documents in 2026 mention GHK-Cu in two ways: as a named example, and inside a laboratory test.

13 April 2026. The TGA’s safety advisory on unapproved peptides gives its examples: “Examples of unapproved peptide products include those containing BPC‑157, GHK‑Cu, TB‑500, retatrutide and CJC‑1295, often supplied in injectable form.” The same advisory states that under the Act “peptide products are regulated as therapeutic goods in Australia”.

5 November 2026. TGA laboratory testing of products from one brand, identified with NSW Police, covered two blends labelled as containing GHK-Cu with other peptides. The TGA reported no detectable TB-500 in either. It did not report a GHK-Cu result. In the same alert it said that “most peptide products, including BPC-157, TB-500 and melanotan I, are prescription-only medicines in Australia”.

23 September 2026. The TGA’s peptide products page set out the cosmetic route quoted above. It does not name GHK-Cu.

Sport Integrity Australia’s peptides page also gives GHK-Cu as one of its examples of unapproved peptide products.

03Is GHK-Cu in the Poisons Standard?

Not by name. On 18 November 2026 we searched the full text of the October 2026 Standard (F2026L01327) for “GHK”, “copper tripeptide”, “prezatide” and “glycyl-L-histidyl” and found no entry.

Scheduling is not approval. The Poisons Standard sets supply controls; the Therapeutic Goods Act decides whether a product may be supplied at all. And in the TGA’s view, any dealing in unapproved peptide products, from import and advertising to manufacture and supply, is unlawful.

The copper group entries. The Standard does schedule copper compounds as a group. Schedule 4, prescription-only medicines, lists “COPPER COMPOUNDS for human use”, with exceptions when separately specified, for internal preparations at or below a stated copper content, and for other preparations at or below a stated percentage. Schedule 6, poisons, lists “COPPER COMPOUNDS” with similar exceptions, plus exceptions for certain pigments and feed additives.

GHK-Cu is a copper(II) complex. Whether a group entry captures a given GHK-Cu product would turn on the product and its copper content. We found no TGA statement applying either entry to GHK-Cu, and we do not make that call here.

04What changed in 2026?

No law naming GHK-Cu changed. What changed is how actively the TGA polices peptides, and how plainly it describes the cosmetic route.

DateTGA action
13 Apr 2026Safety advisory gives GHK-Cu as one of five examples of unapproved peptide products.
7 May 2026Warns that poorly labelled peptide imports will not be released, and that it will notify the Australian Border Force to seize and destroy them.
10 Jun 2026Adds unapproved peptide products to its compliance priorities.
20 Jul 2026Says peptide products are being advertised online for purposes that include cosmetic ones, and that labelling a blank vial counts as manufacture.
17 Aug 2026States: “It is unlawful to import, advertise, manufacture and supply unapproved peptide products in Australia.”
23 Sep 2026Updates its peptide products page, including when a peptide product may be regulated as a cosmetic.
1 Oct 2026The October 2026 Poisons Standard commences. It has no entry for GHK-Cu.
5 Nov 2026Reports testing of two blends labelled with GHK-Cu: no TB-500 detected, and no GHK-Cu result reported.

For the wider Australian rules, including imports and compounding, see are peptides legal in Australia? and is BPC-157 legal in Australia?

05How is GHK-Cu treated in Australian sport?

We searched WADA’s 2026 and 2027 Prohibited Lists for “GHK”, “copper” and “tripeptide” and found no entry. Class S0 covers pharmacological substances not addressed elsewhere on the List that have “no current approval by any governmental regulatory health authority for human therapeutic use”. The List does not say whether GHK-Cu meets that test, and we have not checked its status with every regulator. The 2027 List adds “peptides” to the S0 examples, and WADA’s 2027 notes say an unnamed peptide “may still be prohibited”.

Sport Integrity Australia gives GHK-Cu as an example of an unapproved peptide product. It says “Many unapproved peptides are prohibited in sport” and that a therapeutic use exemption “is unlikely to be granted for an unregistered medicine”. How S0 applies to a given product is for the anti-doping organisation to decide, so athletes should check with Sport Integrity Australia. More: peptides and anti-doping.

06What we don’t know

Whether the copper group entries reach GHK-Cu. No TGA statement we found applies them to it.

Its AICIS status. We did not check whether copper tripeptide-1 is on the Australian Inventory of Industrial Chemicals; the inventory search needs a browser.

The ARTG. We could not search it, since the TGA site timed out for us. We know of no entry.

Enforcement involving GHK-Cu. The TGA’s releases describe seizures and notices by product type, not by compound.

State and territory rules. Poisons laws differ by jurisdiction, and we have not summarised them.

For the research on GHK-Cu, see our GHK-Cu research guide, GHK-Cu on the skin and peptides in skincare. Changes are logged in our regulatory changelog.

This is a plain-English summary of public documents, checked on 18 Nov 2026. It is not legal advice.

RefSources

  1. TGA. Understanding your responsibilities when importing, compounding and supplying unapproved peptide products. Safety advisory, 13 Apr 2026; read on the Internet Archive capture of 10 Aug 2026, the newest (tga.gov.au timed out on 18 Nov 2026). www.tga.gov.au/safety/safety-monitoring-and-information/safe…
  2. TGA. Peptide products. Topic page, last updated 23 Sep 2026; read on the Internet Archive capture of 5 Nov 2026. www.tga.gov.au/resources/explore-topic/peptide-products
  3. TGA. Cosmetics. Topic page, last updated 17 May 2021; read on the Internet Archive capture of 16 May 2026, the newest. www.tga.gov.au/resources/explore-topic/cosmetics
  4. Therapeutic Goods Act 1989, section 3 (definitions) and section 19B. Federal Register of Legislation, Compilation No. 89 (5 Sep 2025), the latest; read 18 Nov 2026. www.legislation.gov.au/C2004A03952/latest/text
  5. Industrial Chemicals Act 2019, section 9 (definition of cosmetic). Federal Register of Legislation, Compilation No. 6 (14 Oct 2024), the latest; read 18 Nov 2026. www.legislation.gov.au/C2019A00012/latest/text
  6. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327): Schedule 4 and Schedule 6 copper compound entries; full-text search for GHK-Cu names. Federal Register of Legislation, registered 30 Sep 2026, commenced 1 Oct 2026; read 18 Nov 2026. www.legislation.gov.au/F2026L01327/latest/text
  7. TGA. TGA testing finds unapproved peptides do not contain what their labels claim. Safety alert, 5 Nov 2026; read on the Internet Archive capture of 15 Nov 2026, the newest. www.tga.gov.au/safety/safety-monitoring-and-information/safe…
  8. TGA. TGA flexes its muscle against illegal peptides and steroids. Media release, 17 Aug 2026; read on the Internet Archive capture of 11 Oct 2026, the newest. www.tga.gov.au/news/media-releases/tga-flexes-its-muscle-aga…
  9. TGA. TGA warning on the risks of importing unapproved peptide products. Safety alert, 7 May 2026; read on the Internet Archive capture of 25 Jul 2026, the newest. www.tga.gov.au/safety/safety-monitoring-and-information/safe…
  10. TGA. Unapproved peptide product promoters and suppliers are put on notice. Media release, 20 Jul 2026; read on the Internet Archive capture of 12 Sep 2026, the newest. www.tga.gov.au/news/media-releases/unapproved-peptide-produc…
  11. TGA. TGA strengthens compliance focus on unapproved peptide products as part of evolving risk response. Media release, 10 Jun 2026; read on the Internet Archive capture of 29 Oct 2026. www.tga.gov.au/news/media-releases/tga-strengthens-complianc…
  12. World Anti-Doping Agency. The 2026 and 2027 Prohibited Lists (S0), and the 2027 Summary of Major Modifications and Explanatory Notes (dated 17 Aug 2026). International Standard; read 18 Nov 2026 (explanatory note on the Internet Archive capture of 8 Oct 2026). www.wada-ama.org/en/prohibited-list
  13. Sport Integrity Australia. Peptides explained. Substance education page; read on the Internet Archive capture of 5 Nov 2026 (sportintegrity.gov.au timed out). www.sportintegrity.gov.au/what-we-do/anti-doping/substance-e…
  14. PubChem. Prezatide copper, CID 71587328: synonyms include copper tripeptide-1, GHK copper and GHK-Cu. Compound record, read 18 Nov 2026. pubchem.ncbi.nlm.nih.gov/compound/71587328

Plain-English summary of public sources, not legal or medical advice. Last checked 18 Nov 2026.

Questions

Is GHK-Cu prescription-only in Australia?

The Poisons Standard does not name GHK-Cu. It has group entries for copper compounds in Schedules 4 and 6, and we found no TGA statement applying them to GHK-Cu. Separately, the TGA says importing, advertising, manufacturing and supplying unapproved peptide products is unlawful, and it gives GHK-Cu as an example of one.

Does the TGA regulate GHK-Cu skin products?

It depends on how the product is presented and used. The TGA says a peptide product promoted, supplied or generally used for a therapeutic purpose is a therapeutic good, and that some peptide products “may be regulated as cosmetics rather than a therapeutic good if their ingredients, claims, presentation and intended use are limited to cosmetic purposes”. It does not assess cosmetics unless they make therapeutic claims; cosmetic ingredients are regulated as industrial chemicals.

Does a “research use only” label change GHK-Cu’s status in Australia?

No. The TGA says such disclaimers alone do not change a product’s regulatory status, permit importation or remove advertising and supply obligations.

Is GHK-Cu prohibited in Australian sport?

Neither WADA’s 2026 nor its 2027 List names it. WADA’s 2027 notes say an unnamed peptide “may still be prohibited”, and Sport Integrity Australia, which gives GHK-Cu as an example of an unapproved peptide product, says “many unapproved peptides are prohibited in sport”. Athletes should check with Sport Integrity Australia.

Has the TGA tested GHK-Cu products?

In November 2026 the TGA reported tests on two blends from one brand labelled as containing GHK-Cu with other peptides. It found no detectable TB-500 in either and did not report a GHK-Cu result.

Evidence before hype.

One email a week: new research explained and regulatory changes. No prices, no hype.

Get the 6:00 brief

Free. Unsubscribe any time.

Written by 6AM Research. Drafted from primary sources; every claim links to its source, and the page is dated. Editorial policy · How we check every page